MHMing-Chia Hsieh

Ming-Chia Hsieh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ming-Chia Hsieh has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Yi-Ting Hsieh

    3 shared publications
  • I-Chieh Mao

    2 shared publications
  • Jeng-Fu Kuo

    2 shared publications
  • Ming-Chun Kuo

    From the Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung (M-CK); Chang Gung University College of Medicine (M-CK); National University of Kaohsiung, Kaohsiung (S-JC); Division of Endocrinology and Metabolism, Department of Internal Medicine, Changhua Christian Hospital, Changhua (M-CH); and Graduate Institute of Integrated Medicine, China Medical University, Taiwan (M-CH)

    2 shared publications
  • Shih-Te Tu

    2 shared publications
  • Charles T.‐C. Lee

    Department of Public Health, Kaohsiung Medical University, Kaohsiung, Taiwan

    1 shared publication

Latest Publications

  • Open Access

    Subnormal Estimated Glomerular Filtration Rate Strongly Predict Incident Cardiovascular Events in Type 2 Diabetic Chinese Population With Normoalbuminuria

    by Yi-Ting Hsieh, Jeng-Fu Kuo, Shih-Li Su, Jung-Fu Chen, Hung-Chun Chen, Ming-Chia Hsieh

    No study has evaluated whether subnormal estimated glomerular filtration rate (eGFR) (between 61 and 90 mL/min) and high normal albumin–creatinine ratio (ACR) (<30 mg/g) are associated with cardiovascular (CV) events and mortality in type 2 diabetic (T2DM) patients with normoalbuminuria. We observed a longitudinal cohort study of 1291 T2DM patients with normoalbuminuria who were receiving intensified multifactorial treatment from 2004 to 2008. Cox regression models were used to evaluate eGFR and ACR as the risk factors of major CV events (nonfatal myocardial infarction and stroke) and mortality. During the 4-year period, 56 patients died and 159 patients developed major CV events. We found eGFR, but not ACR, to be associated with major CV events. Compared to those with eGFR higher than 90 mL/min, patients with subnormal eGFR (HR: 3.133, 1.402–7.002, P = 0.005) were at greater risk of incident major CV events. Extremely low eGFR (<30 mL/min) was associated with mortality only in patients under 65 years old. Subnormal eGFR was a strong predictor of major CV events in diabetic patients with normoalbuminuria. Normoalbuminuric diabetic patients with subnormal eGFR may need intensive CV risk factor intervention to prevent and treat CV events.


  • Open Access

    Colchicine Significantly Reduces Incident Cancer in Gout Male Patients

    by Ming-Chun Kuo, Shun-Jen Chang, Ming-Chia Hsieh

    Patients with gout are more likely to develop most cancers than subjects without gout. Colchicine has been used for the treatment and prevention of gouty arthritis and has been reported to have an anticancer effect in vitro. However, to date no study has evaluated the relationship between colchicine use and incident cancers in patients with gout. This study enrolled male patients with gout identified in Taiwan's National Health Insurance Database for the years 1998 to 2011. Each gout patient was matched with 4 male controls by age and by month and year of first diagnosis, and was followed up until 2011. The study excluded those who were diagnosed with diabetes or any type of cancer within the year following enrollment. We calculated hazard ratio (HR), aged-adjusted standardized incidence ratio, and incidence of 1000 person-years analyses to evaluate cancer risk. A total of 24,050 male patients with gout and 76,129 male nongout controls were included. Patients with gout had a higher rate of incident all-cause cancers than controls (6.68% vs 6.43%, P = 0.006). A total of 13,679 patients with gout were defined as having been ever-users of colchicine and 10,371 patients with gout were defined as being never-users of colchicine. Ever-users of colchicine had a significantly lower HR of incident all-cause cancers than never-users of colchicine after adjustment for age (HR = 0.85, 95% CI = 0.77-0.94; P = 0.001). In conclusion, colchicine use was associated with a decreased risk of incident all-cause cancers in male Taiwanese patients with gout.


  • Open Access

    The Association Between Body Mass Index and All-Cause Mortality in Patients With Type 2 Diabetes Mellitus

    by Jeng-Fu Kuo, Yi-Ting Hsieh, I-Chieh Mao, Shi-Dou Lin, Shih-Te Tu, Ming-Chia Hsieh

    Abundances of study in different population have noted that obese cardiovascular disease (CVD) patients have a better prognosis than leaner patients, which refer to the phenomenon of obesity paradox. However, data on the association between body mass index (BMI) and mortality among Asian patients are limited, especially in patients with type 2 diabetes mellitus (T2DM). We investigate the association between BMI and all-cause mortality in Taiwanese patients with T2DM to define the optimal body weight for health.We conducted a longitudinal cohort study of 2161 T2DM patients with a mean follow-up period of 66.7 ± 7.5 months. Using Cox regression models, BMI was related to the risk of all-cause mortality after adjusting all confounding factors.A U-shaped association between BMI and all-cause mortality was observed among all participants. Those with BMIs 30.0 kg/m (BMIs 30.0-32.5 kg/m: hazard ratio 1.670, P < 0.001; BMIs 32.5-35.0 kg/m: hazard ratio, 2.632, P < 0.001). This U-shaped association remained when we examined the data by sex, age, smoking, and kidney function.Our study found a U-shaped relationship between all-cause mortality and BMI in Asian patients with T2DM, irrespective of age, sex, smoking, and kidney function. BMI <30 kg/m should be regarded as a potentially important target in the weight management of T2DM.


  • Open Access

    Type 2 Diabetes : An Independent Risk Factor for Tuberculosis: A Nationwide Population-Based Study

    by Ming-Chun Kuo, Sheng-Hao Lin, Ching-Hsiung Lin, I-Chieh Mao, Shun-Jen Chang, Ming-Chia Hsieh

    Tuberculosis continues to be a major global health problem. We wanted to investigate whether Type 2 diabetes was a risk factor for tuberculosis in an Asian population. From Taiwan’s National Health Insurance Research Database, we collected data from 31,237 female patients with type 2 diabetes and 92,642 female controls and 32,493 male patients with type 2 diabetes and 96,977 male controls. Cox proportional hazard regression was performed to evaluate independent risk factors for tuberculosis in all patients and to identify risk factors in patients with type 2 diabetes. During the study period, both female (standardized incidence ratio (SIR): 1.40, p<0.01) and male (SIR: 1.48, p<0.01) patients with type 2 diabetes were found to have a significantly higher rate of incident tuberculosis than the control group. Type 2 diabetes (HR:1.31, 1.23–1.39, p<0.001) was significantly associated with tuberculosis after adjusting sex, age, bronchiectasis, asthma and chronic obstructive lung disease. Patients with type 2 diabetes have a higher risk of tuberculosis compared to control subjects after adjusting for confounding factors. The current diabetes epidemic may lead to a resurgence of tuberculosis in endemic regions. Therefore, preventive measures, including addressing the possibility that type 2 diabetes increase the individual’s susceptibility for incident TB, should be taken to further reduce the incidence of tuberculosis.


  • Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population‐based study

    by Charles T.‐C. Lee, I‐Chieh Mao, Ching‐Hsiung Lin, Sheng‐Hao Lin, Ming‐Chia Hsieh

    Background: Type 2 diabetes mellitus (DM) is a common medical disorder and a leading cause of morbidity and mortality worldwide. We investigated whether chronic obstructive pulmonary disease (COPD) was the risk factor for type 2 diabetes in an Asian population.Materials and methods: From Taiwan's National Health Insurance Research Database, we collected data from 16 088 patients, including 8044 COPD patients and 8044 age‐ and gender‐ matched control subjects. Cox proportional hazard regression was performed to evaluate independent risk factors for type 2 diabetes in all patients and identify risk factors in patients with COPD.Results: During the 5·5‐year follow‐up, patients with COPD were found to have a significantly higher rate of incident type 2 diabetes than the control group (P < 0·001). COPD was significantly associated with type 2 diabetes hazard ratio (HR : 1·41, 1·23–1·63, P < 0·001) after adjusting sex, age, residential area, insurance premium, steroid use, hypertriglycemia, hypertension, coronary artery disease (CAD) and cerebrovascular disease. Cox regression analysis showed that hypertension (HR : 1·55, 1·33–1·80, P < 0·001) and hypertriglycemia (HR : 1·48, 1·15–1·90, P = 0·002) were important risk factors for type 2 diabetes in patients with COPD.Conclusions: Patients with COPD have a higher risk of type 2 diabetes compared with control subjects after adjusting for confounding factors such as sex, age, residential area, insurance premium, steroid use, hypertriglycemia, hypertension, CAD and cerebrovascular disease. Continuous surveillance of signals of dysglycemia may be incorporated into care programmes for patients with COPD.


  • Obesity and low target attainment rates in Chinese with type 2 diabetes

    by Xing-Bo Cheng, Yi-Ting Hsieh, Shih-Te Tu, Ming-Chia Hsieh


  • Visit‐to‐visit variability in blood pressure strongly predicts all‐cause mortality in patients with type 2 diabetes: a 5·5‐year prospective analysis

    by Yi‐Ting Hsieh, Shih‐Te Tu, Tzu‐Jung Cho, Shun‐Jen Chang, Jung‐Fu Chen, Ming‐Chia Hsieh

    Eur J Clin Invest 2012; 42 (3): 245–253 Background  Elevations in blood pressure and visit‐to‐visit variability have been found to significantly increase the risk of cardiovascular morbidity and mortality in nondiabetic individuals. This study has assessed the association between all‐cause mortality and blood pressure parameters [systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), mean arterial pressure (MAP) and visit‐to‐visit variability] in patients with type 2 diabetes.Materials and methods  A longitudinal cohort study of 2161 patients with type 2 diabetes and a mean follow‐up period of 66·7 ± 7·5 months. Using Cox regression models, blood pressure parameters were related to the risk of all‐cause mortality.Results  Visit‐to‐visit variability in SBP [HR: 1·048 (95% CI: 1·005–1·092; P = 0·03)], DBP [HR: 1·090 (95% CI: 1·021–1·163; P = 0·01)] and MAP [HR: 1·099 (95% CI: 1·033–1·170; P = 0·003)] significantly predicted all‐cause mortality in patients with type 2 diabetes after adjusting for baseline data, mean follow‐up blood pressure profiles and HbA1c. Visit‐to‐visit variability in PP [HR: 1·139 (95% CI: 1·030–1·258; P = 0·01)] significantly predicted cardiovascular mortality. Neither baseline nor follow‐up SBP, DBP, PP nor MAP was significantly associated with all‐cause and cardiovascular mortality after adjusting for blood pressure variability. The risk of all‐cause mortality with a mean follow‐up SBP has a U‐shaped distribution. Patients with a mean follow‐up DBP > 90 mmHg were at higher risk of mortality than those with DBP < 90 mmHg.Conclusions  Visit‐to‐visit variability in blood pressure was significantly associated with all‐cause mortality independent of mean BP in patients with type 2 diabetes. The data for blood pressure variability might be regarded as a potentially important therapeutic target in the management of type 2 diabetes.